1. Home
  2. AOD vs ABCL Comparison

AOD vs ABCL Comparison

Compare AOD & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOD
  • ABCL
  • Stock Information
  • Founded
  • AOD 2006
  • ABCL 2012
  • Country
  • AOD United Kingdom
  • ABCL Canada
  • Employees
  • AOD N/A
  • ABCL N/A
  • Industry
  • AOD Investment Managers
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AOD Finance
  • ABCL Health Care
  • Exchange
  • AOD Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • AOD 988.9M
  • ABCL 1.1B
  • IPO Year
  • AOD N/A
  • ABCL 2020
  • Fundamental
  • Price
  • AOD $9.44
  • ABCL $4.72
  • Analyst Decision
  • AOD
  • ABCL Strong Buy
  • Analyst Count
  • AOD 0
  • ABCL 5
  • Target Price
  • AOD N/A
  • ABCL $8.00
  • AVG Volume (30 Days)
  • AOD 423.5K
  • ABCL 3.7M
  • Earning Date
  • AOD 01-01-0001
  • ABCL 11-03-2025
  • Dividend Yield
  • AOD 12.95%
  • ABCL N/A
  • EPS Growth
  • AOD 213.63
  • ABCL N/A
  • EPS
  • AOD 1.93
  • ABCL N/A
  • Revenue
  • AOD $72,962,082.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • AOD N/A
  • ABCL $16.99
  • Revenue Next Year
  • AOD N/A
  • ABCL $63.73
  • P/E Ratio
  • AOD $4.44
  • ABCL N/A
  • Revenue Growth
  • AOD N/A
  • ABCL N/A
  • 52 Week Low
  • AOD $6.99
  • ABCL $1.89
  • 52 Week High
  • AOD $9.14
  • ABCL $5.82
  • Technical
  • Relative Strength Index (RSI)
  • AOD 78.35
  • ABCL 58.52
  • Support Level
  • AOD $9.36
  • ABCL $4.32
  • Resistance Level
  • AOD $9.14
  • ABCL $4.85
  • Average True Range (ATR)
  • AOD 0.06
  • ABCL 0.28
  • MACD
  • AOD 0.02
  • ABCL 0.05
  • Stochastic Oscillator
  • AOD 96.40
  • ABCL 87.25

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: